NMDA receptors are key regulators of synaptic plasticity, and their hypofunction is thought to contribute to the pathophysiology of CNS disorders. Furthermore, NMDA receptors participate in the formation, maintenance, and elimination of synapses. The consequences of NMDA receptor hypofunction on synapse biology were explored in a genetic mouse model, in which the levels of NMDA receptors are reduced to 10% of normal levels (i.e., NR1-knockdown mice). In these mice, synapse number is reduced in an agedependent manner; reductions are observed at the postpubertal age of 6 wk, but normal at 2 wk of age. Efforts to uncover the biochemical underpinnings of this phenomenon reveal synapsespecific reductions in 14-3-3ε protein and in Disrupted in Schizophrenia-1 (DISC1), two schizophrenia susceptibility factors that have been implicated in the regulation of spine density. Subchronic administration of MK-801, an NMDA receptor antagonist, produces similar synaptic reductions in both spine density and DISC1, indicating that synaptic levels of DISC1 are regulated by NMDA receptor function. The synaptic reduction of DISC1 and 14-3-3ε is developmentally correlated with the age-dependent decrease in striatal spine density.glutamate | neurodevelopmental A defining feature of neurons is their ability to alter the number and strength of synaptic connections with experience. At the cellular level, changes in synapse number, or postsynaptic spine density, occur with learning and memory formation (1) or exposure to psychoactive drugs (2), and in neurodevelopmental diseases including schizophrenia (3, 4), fragile-X mental retardation (5), and Rett syndrome (6). At the molecular level, NMDA-type glutamate receptors have long been appreciated for their role in the formation and maintenance of glutamatergic synapses (7), and as mediators of synaptic plasticity (8). Several studies have shown a positive correlation between NMDA receptor activity and spine density (9-12), with notable exceptions (13,14). However, the molecular mechanisms by which NMDA receptors regulate spine density remain to be fully elucidated. In the case of disease states such as schizophrenia, a fuller understanding of this molecular machinery may point to new therapeutic strategies.The striatum represents an ideal brain region in which to further explore the biochemical mechanisms by which NMDA receptors regulate spine density, because the vast majority of neurons (95%) within this brain structure are medium spiny neurons (MSNs), which have densely spinous dendrites, upon which glutamate and dopamine afferents converge (15,16). This neuronal homogeneity allows for ex vivo biochemical preparation of synaptic proteins from a nearly homogenous neuronal substrate. MSNs are thought to be a principal site of action of antipsychotic drugs because they express the highest levels of D2 dopamine receptors (17). Furthermore, they participate in many of the cognitive and limbic behaviors that are altered in schizophrenia (17, 18).We hypothesized that reduced NMDA receptor funct...